PRMTs and miRNAs: functional cooperation in cancer and beyond

Jiamin Jin, Matthew Martin, Antja Voy Hartley, Tao Lu

Research output: Contribution to journalReview article

Abstract

Epigenetic modulators play pivotal roles in directing gene expression for the maintenance of normal cellular functions. However, when these modulators are aberrantly regulated, this can result in a variety of disease states, including cancer. One class of epigenetic regulators, protein arginine methyltransferases (PRMTs), have been shown to play critical roles in disease through methylation of arginine residues (R) on histone or non-histone proteins. Quite different from PRMTs, microRNAs (miRNAs) belong to the family of modulators known as noncoding RNAs (ncRNA) that act to regulate gene expression via RNA-mediated gene silencing. Importantly, miRNAs are frequently dysregulated and contribute to the progression of cancer and other conditions, including neurological and cardiovascular diseases. Recently, numerous studies have shown that miRNAs and other epigenetic enzymes can co-regulate each other. This review highlights multiple nodes of interaction between miRNAs and PRMTs and also discusses how this interplay might open up promising opportunities for drug development for the treatment of cancer and other diseases.

Original languageEnglish (US)
Pages (from-to)1676-1686
Number of pages11
JournalCell Cycle
Volume18
Issue number15
DOIs
StatePublished - Aug 3 2019

Fingerprint

Protein-Arginine N-Methyltransferases
MicroRNAs
Epigenomics
Neoplasms
Gene Expression
Untranslated RNA
Gene Silencing
Histones
Methylation
Arginine
Cardiovascular Diseases
Maintenance
RNA
Enzymes
Pharmaceutical Preparations
Proteins

Keywords

  • Cancer
  • disease
  • miRNA
  • PRMTs

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Cite this

PRMTs and miRNAs : functional cooperation in cancer and beyond. / Jin, Jiamin; Martin, Matthew; Hartley, Antja Voy; Lu, Tao.

In: Cell Cycle, Vol. 18, No. 15, 03.08.2019, p. 1676-1686.

Research output: Contribution to journalReview article

Jin, Jiamin ; Martin, Matthew ; Hartley, Antja Voy ; Lu, Tao. / PRMTs and miRNAs : functional cooperation in cancer and beyond. In: Cell Cycle. 2019 ; Vol. 18, No. 15. pp. 1676-1686.
@article{8242a860ce3347d0a0b3f050177717e6,
title = "PRMTs and miRNAs: functional cooperation in cancer and beyond",
abstract = "Epigenetic modulators play pivotal roles in directing gene expression for the maintenance of normal cellular functions. However, when these modulators are aberrantly regulated, this can result in a variety of disease states, including cancer. One class of epigenetic regulators, protein arginine methyltransferases (PRMTs), have been shown to play critical roles in disease through methylation of arginine residues (R) on histone or non-histone proteins. Quite different from PRMTs, microRNAs (miRNAs) belong to the family of modulators known as noncoding RNAs (ncRNA) that act to regulate gene expression via RNA-mediated gene silencing. Importantly, miRNAs are frequently dysregulated and contribute to the progression of cancer and other conditions, including neurological and cardiovascular diseases. Recently, numerous studies have shown that miRNAs and other epigenetic enzymes can co-regulate each other. This review highlights multiple nodes of interaction between miRNAs and PRMTs and also discusses how this interplay might open up promising opportunities for drug development for the treatment of cancer and other diseases.",
keywords = "Cancer, disease, miRNA, PRMTs",
author = "Jiamin Jin and Matthew Martin and Hartley, {Antja Voy} and Tao Lu",
year = "2019",
month = "8",
day = "3",
doi = "10.1080/15384101.2019.1629791",
language = "English (US)",
volume = "18",
pages = "1676--1686",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "15",

}

TY - JOUR

T1 - PRMTs and miRNAs

T2 - functional cooperation in cancer and beyond

AU - Jin, Jiamin

AU - Martin, Matthew

AU - Hartley, Antja Voy

AU - Lu, Tao

PY - 2019/8/3

Y1 - 2019/8/3

N2 - Epigenetic modulators play pivotal roles in directing gene expression for the maintenance of normal cellular functions. However, when these modulators are aberrantly regulated, this can result in a variety of disease states, including cancer. One class of epigenetic regulators, protein arginine methyltransferases (PRMTs), have been shown to play critical roles in disease through methylation of arginine residues (R) on histone or non-histone proteins. Quite different from PRMTs, microRNAs (miRNAs) belong to the family of modulators known as noncoding RNAs (ncRNA) that act to regulate gene expression via RNA-mediated gene silencing. Importantly, miRNAs are frequently dysregulated and contribute to the progression of cancer and other conditions, including neurological and cardiovascular diseases. Recently, numerous studies have shown that miRNAs and other epigenetic enzymes can co-regulate each other. This review highlights multiple nodes of interaction between miRNAs and PRMTs and also discusses how this interplay might open up promising opportunities for drug development for the treatment of cancer and other diseases.

AB - Epigenetic modulators play pivotal roles in directing gene expression for the maintenance of normal cellular functions. However, when these modulators are aberrantly regulated, this can result in a variety of disease states, including cancer. One class of epigenetic regulators, protein arginine methyltransferases (PRMTs), have been shown to play critical roles in disease through methylation of arginine residues (R) on histone or non-histone proteins. Quite different from PRMTs, microRNAs (miRNAs) belong to the family of modulators known as noncoding RNAs (ncRNA) that act to regulate gene expression via RNA-mediated gene silencing. Importantly, miRNAs are frequently dysregulated and contribute to the progression of cancer and other conditions, including neurological and cardiovascular diseases. Recently, numerous studies have shown that miRNAs and other epigenetic enzymes can co-regulate each other. This review highlights multiple nodes of interaction between miRNAs and PRMTs and also discusses how this interplay might open up promising opportunities for drug development for the treatment of cancer and other diseases.

KW - Cancer

KW - disease

KW - miRNA

KW - PRMTs

UR - http://www.scopus.com/inward/record.url?scp=85069497551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069497551&partnerID=8YFLogxK

U2 - 10.1080/15384101.2019.1629791

DO - 10.1080/15384101.2019.1629791

M3 - Review article

C2 - 31234694

AN - SCOPUS:85069497551

VL - 18

SP - 1676

EP - 1686

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 15

ER -